Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Sanchez

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Neuropharmacology|October 1, 1991
Banisterine and Parkinson's diseaseJ R Sanchez-Ramos
Neurologic Clinics|August 1, 1993
PsychostimulantsJ R Sanchez-Ramos
Pharmacology, Biochemistry, and Behavior|November 1, 1977
Second-order schedules of intravenous drug self-administration in rhesus monkeysJ R Sanchez-Ramos, C R Schuster
European Neurology|January 1, 1992
Autonomic dysfunction in men with Parkinson's diseaseC Singer, W J Weiner, J R Sanchez-Ramos
Archives of Neurology|December 1, 1996
Visual hallucinations associated with Parkinson diseaseJ R Sanchez-Ramos, R Ortoll, G W Paulson
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1988
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapyS A Factor, J R Sanchez-Ramos, W J Weiner
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's diseaseW J Weiner, S A Factor, J R Sanchez-Ramos
Journal of Neurochemistry|June 1, 1988
Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidenceJ R Sanchez-Ramos, P Michel, W J Weiner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Sleep disorders and sleep effect in Parkinson's diseaseS A Factor, T McAlarney, J R Sanchez-Ramos, et al.
Journal of Neurochemistry|January 1, 1992
21-aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicityJ R Sanchez-Ramos, S Song, D C Mash, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Neuropharmacology|October 1, 1991
Banisterine and Parkinson's diseaseJ R Sanchez-Ramos
Neurologic Clinics|August 1, 1993
PsychostimulantsJ R Sanchez-Ramos
Pharmacology, Biochemistry, and Behavior|November 1, 1977
Second-order schedules of intravenous drug self-administration in rhesus monkeysJ R Sanchez-Ramos, C R Schuster
European Neurology|January 1, 1992
Autonomic dysfunction in men with Parkinson's diseaseC Singer, W J Weiner, J R Sanchez-Ramos
Archives of Neurology|December 1, 1996
Visual hallucinations associated with Parkinson diseaseJ R Sanchez-Ramos, R Ortoll, G W Paulson
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1988
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapyS A Factor, J R Sanchez-Ramos, W J Weiner
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's diseaseW J Weiner, S A Factor, J R Sanchez-Ramos
Journal of Neurochemistry|June 1, 1988
Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidenceJ R Sanchez-Ramos, P Michel, W J Weiner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Sleep disorders and sleep effect in Parkinson's diseaseS A Factor, T McAlarney, J R Sanchez-Ramos, et al.
Journal of Neurochemistry|January 1, 1992
21-aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicityJ R Sanchez-Ramos, S Song, D C Mash, et al.
Pageof 3